Skip to main content
Wolfson Institute of Population Health

Quality of life after cytoreductive surgery in advanced ovarian cancer

Published:
news image

A prospective multicentre observational study conducted in gynaecological cancer surgery centres in the UK, India, and Australia has investigated quality of life after surgical resection for advanced ovarian cancer among participants in the SOCQER2 cohort. Outcomes were measured according to surgical complexity (low, intermediate, or high). Global quality of life of patients in all three surgical categories improved at 12 months post operation compared with pre-surgery baseline. Overall, there were no clinically or statistically meaningful differences in global scores in comparing the three SCS groups, but there was a small statistically significant improvement in all groups over time. Co-author Professor Ranjit Manchanda, of the WIPH Centre for Prevention, Detection and Diagnosis, was PI at the Bart’s Health site for the trial. The authors conclude that: Patients undergoing high complexity surgery can be reassured that by 12 months post-operation, most will have better quality of life than immediately before surgery.